IMUC
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2022 Q4 | -0.00 | $0 | -$687,932 |
| 2022 Q3 | -0.01 | $0 | $0 |
| 2022 Q2 | -0.01 | $0 | — |
| 2022 Q1 | -0.01 | $0 | -$553 |
| 2021 Q4 | -0.08 | $0 | -$851 |
| 2021 Q3 | -0.01 | $0 | $0 |
| 2021 Q1 | -0.01 | $0 | -$592,972 |
| 2020 Q4 | -0.04 | $0 | -$1,285 |